Don’t Eat the Yellow Rice: The Danger of Deploying Vitamin A Golden Rice
By Ted Greiner,
Independent Science News
| 07. 11. 2016
What better way to discredit your critics than to rope in 107 naive Nobel Prize winners (all without relevant expertise) to criticize your opposition?
But such tactics are not new. Long ago, the GMO industry spent well over $50 million to promote “Golden Rice” as the solution to vitamin A deficiency in low income countries. They did so well before the technology was completely worked out, let alone tested. Let alone consumer acceptability tested. Let alone subjecting it to standard phase 2 and 3 trials to see if it could ever solve problems in the real world.
So why has this apparently straightforward scientific project not reached completion after so many decades?
Because the purpose of Golden Rice was never to solve vitamin A problems. It never could and never will. It’s purpose from the beginning was to be a tool for use in shaming GMO critics and now to convince Nobel Laureates to sign on to something they didn’t understand.
I worked with a conventional fortified rice technology (Ultra Rice) for years for the NGO PATH in...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 06.30.2026
A research program at the National Institutes of Health released the world’s largest database of human genomes and paired them with clinical data, officials announced Tuesday, paving the way for a new era of study in personalized medicine.
The All...
By Sarah Norcross, Sandy Starr, Amanda Cooney, and Anneliese Burton, BioNews | 07.06.2026
By Mustapha Bature Sallama, Modern Ghana | 06.11.2026
In much of West Africa, a woman who cannot bear children does not merely face a medical condition. She faces a verdict. Her marriage may unravel. Her community may turn cold. Her identity, in a social order that ties womanhood...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...